Safety of high-dose tirofiban in patient undergoing coronary angioplasty
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2011
At a glance
- Drugs Tirofiban (Primary) ; Clopidogrel
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Adverse reactions
- Acronyms SANTISS
- 01 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Jul 2008 Status changed from initiated to recruiting as reported by ClinicalTrials.gov.
- 11 Dec 2007 New trial record.